Presentation – Abliva

23 June, 2020

Abliva – Virtual Capital Markets Day today at 3.00 p.m.

Abliva AB (Nasdaq Stockholm: ABLI) – today, 23 June 2020, holds a virtual Capital Markets Day. The theme of the day will be the company's new strategic focus on primary mitochondrial disease, the most ...

16 June, 2020

Abliva invites you to a virtual Capital Markets Day on June 23

Abliva AB (Nasdaq Stockholm: ABLI), invites you to a virtual Capital Markets Day on 23 June at 3.00 p.m. - 4.30 p.m. The theme of the day will be the company's new strategic focus on primary mitochond ...

1 June, 2020

Abliva arranges virtual Capital Markets Day on 23 June

Abliva AB (Nasdaq Stockholm: ABLI), invites to a virtual capital markets day on 23 June at 3.00 - 4.30 p.m. CEST. The theme of the day will be the company's new strategic focus on primary mitochondria ...

9 March, 2020

NeuroVive – company presentations March/April 2020

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) informs about its scheduled company presentations for March and April 2020.

9 October, 2019

NeuroVive – Capital Markets Day today at 1:30 p.m. CEST/7:30 a.m. EST.

Lund, Sweden, 9 October 2019, NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), holds today, on October 9, 2019, a Capital Markets Day for analysts, investors and media. The program i ...

20 August, 2019

Save the date: NeuroVive to host Capital Markets Day in Stockholm on 9 October, 2019

Lund, 20 August 2019, NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced that the company will host a Capital Markets Day in Stockholm on 9 October, 2019, for investors, ...

18 January, 2019

NeuroVive – company presentations January 2019

Lund, Sweden, 18 January 2019 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX:NEVPF) informs on its scheduled company presentation for January 2019.

20 April, 2018

NeuroVive presents NVP025 mitochondrial myopathy project progress at Mitochondrial Medicine conference

Lund, Sweden, 20 April 2018, NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced that its mitochondrial myopathy project, NVP025, has been selected for an oral presentati ...

16 March, 2018

NeuroVive to present at 2nd Annual H.C. Wainwright NASH Investor Conference

Lund, Sweden, 16 March 2018, NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced that its Chief Medical Officer Magnus Hansson will present the company's non-alcoholic st ...

6 March, 2018

NeuroVive presents at the Stockholm Corporate Finance Life Science Seminar

Lund, Sweden, 6 March 2018, NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) participates in the Stockholm Corporate Finance Life Science Seminar at Operaterassen on 7 March 2018 at 1 ...

3 January, 2018

NeuroVive to Present at the 10th Annual Biotech Showcase Conference

Lund, Sweden, 3 January 2018 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), today announced that the company is scheduled to present the 10th Annual Biotech Showcase Conference, ...

15 November, 2017

NeuroVive presents TBI clinical study results at Nordic Neurotrauma Conference

Lund, Sweden, 15 November 2017 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced that the company will present data from its clinical phase IIa study on traumatic bra ...